Resumo

CANENCIA MALDONADO, F.; CABANES MARISCAL, M.ªA.; TABAKOV, A.  e  APARICIO HERNANDEZ, R.. Possitive assesment of drugs: september, October and November 2014. Sanid. Mil. [online]. 2015, vol.71, n.2, pp.98-102. ISSN 1887-8571.  https://dx.doi.org/10.4321/S1887-85712015000200006.

The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in December of 2014, January and February of 2015, and considered of interest to the healthcare profesional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.

Palavras-chave : Autologous corneal epithelial cells; Holoclar^®; Naltrexona/Bupropión; Mysimba^®; Levoflosacino; Quinsair^®; Safinamida Xadago^®; Dalbavancina; Xydalba^®; Lamiduvina/Raltegavir; Dutrebis^®; Ciclosporina; Ikervis^®; Cangrelor; Kengresal^®; Oritavancina; Orbactiv^®; Liraglutida; Saxenda^®; Fosfato de Telizolida; Sivextro^®; Tolvaptan; Jinarc^®; Ceritinib; Zykadia^®.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )